University of Reading
Reading, UK, RG6 6BZ, United Kingdom
NCT Number: NCT05981690
This preliminary study aims to examine the outcomes from a therapist guided, parent-led, CBT treatment for preadolescent children (aged 5 to 12 years old) with OCD.
Specifically, this study aims to:
1. Examine outcomes for children who receive the therapist guided, parent-led, CBT treatment for preadolescent children with OCD. 2. Examine parents' experiences and views about the acceptability of the treatment approach.
Looking for future studies?
Notify Me5 year–12 year
All sexes
Interventional
Not applicable
Reading, UK, RG6 6BZ, United Kingdom
This study adapted an existing therapist guided, parent-led CBT intervention for children with anxiety difficulties, to ensure suitability for preadolescent children with OCD.
This preliminary study aims to examine the outcomes from a therapist guided, parent-led, CBT treatment for preadolescent children (aged 5 to 12 years old) with OCD.
Specifically, this study aims to:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Children
Inclusion criteria
Inclusion criteria
Exclusion criteria
Children
Exclusion criteria
Parents
Exclusion criteria
This treatment was adapted from an existing evidence based therapist guided parent-led CBT intervention for preadolescent children with anxiety difficulties. It consists of 6 to 8 treatment individual treatment sessions where parents learn CBT techniques to apply at home with their child
Time frame: Change from pre-baseline phase, within one-week post-treatment, one-month follow-up
Diagnostic interview. Higher scores indicate higher severity of OCD
Time frame: Change from pre-baseline phase, within one-week post-treatment, one-month follow-up
Diagnostic interview. Indicates presence/absence of anxiety, OCD, and externalising difficulties. Higher severity scores indicate greater severity of difficulties.
Time frame: Weekly during baseline and intervention phase; one month follow up
Symptom measure. Higher scores indicate greater OCD symptoms and impairment.
Time frame: Weekly during baseline and intervention phase; one month follow up
Symptom measure. Higher scores indicate greater levels of family accommodation of OCD.
Time frame: Weekly during intervention phase; one month follow up
Families identify up to 3 personalised goals to work towards during the intervention. Goals are rated weekly by the parent form 0 (no goal progress) to 10 (goal achieved)
Time frame: Weekly during intervention phase; one month follow-up
Therapeutic alliance/treatment acceptability. Higher scores indicate greater acceptability.
Time frame: one month follow-up
Treatment acceptability. 6 questionnaire items on a Likert scale from strongly disagree to strongly agree. 4 open ended questions regarding treatment acceptability.
Time frame: Weekly during baseline and intervention phase; one month follow up
3 questionnaire items devised by study authors to assess parents' report of their knowledge and confidence to help their child to overcome OCD. Items scored from 0 (no new learning) to 5 (learned a lot)
Time frame: Weekly during intervention phase; one month follow up
2 questionnaire items devised by study authors to assess parents' perceptions of whether their child had learned new information about their fears and their ability to cope in feared situations, without performing their compulsions. Items scored from 0 (no new learning) to 5 (learned a lot)
University of Reading
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06731426
OCD
Milwaukee, Wisconsin, United States
View Trial DetailsNCT06282146
Anxiety Disorders, Behavior
Boston, Massachusetts, United States
View Trial DetailsNCT04075890
Decision-Making, OCD
Los Angeles, California, United States
View Trial DetailsNCT06231095
OCD
Wroclaw, Lower Silesian Voivodeship, Poland
View Trial Details